We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about sebaceous carcinoma, a rare and aggressive skin cancer affecting sebaceous glands, often on the eyelids. Discover its symptoms, causes, diagnosis, treatment, and prevention.

What is Sebaceous Carcinoma? Sebaceous carcinoma is a rare but aggressive form of skin cancer that originates in the sebaceous glands. These glands are responsible for producing sebum, an oily substance that lubricates the skin and hair, keeping them moisturized and protected. While most skin cancers, such as basal cell carcinoma and squamous cell carcinoma, are common and highly treatable, sebaceous carcinoma presents a more challenging diagnosis and outlook due to its aggressive nature and tendency to recur. It most commonly affects the eyelids but can develop in any area of the body where sebaceous glands are present, including the face, scalp, and ears. Understanding Sebaceous Glands Sebaceous glands are found throughout the body, typically associated with hair follicles. They are most concentrated on the face and scalp. Their primary function is to secrete sebum, which plays a crucial role in maintaining skin barrier function and protecting against environmental factors, including UV radiation. The presence of these glands means that sebaceous carcinoma can potentially arise anywhere on the skin, though its predilection for the eyelids is notable. Symptoms of Sebaceous Carcinoma Recognizing the symptoms of sebaceous carcinoma is vital for early detection and treatment. The signs can often be subtle and may be mistaken for more common, benign conditions. On the Eyelids: The most common presentation is a small, painless bump or nodule on the eyelid, often on the upper eyelid. It might resemble a pimple, stye, or a chalazion. Other symptoms include a sore on the eyelid that doesn't heal, or a general thickening of the eyelid tissue along the lash line. On Other Areas of the Body: When sebaceous carcinoma develops outside the eyelids, it might appear as a small, firm, pinkish or yellowish growth or a mole that gradually changes in size, shape, or color. It is important to note that sebaceous carcinoma can sometimes appear relatively benign initially, making early diagnosis difficult. What Does Sebaceous Carcinoma Look Like? Visually, sebaceous carcinoma can be deceptive. On the eyelid, it often presents as a small, firm, and painless lump. Many individuals might initially dismiss it as a common eye irritation like pink eye, a stye, or a chalazion. When it occurs elsewhere on the body, it might start as a small, pinkish or yellowish growth or a mole that shows signs of progression over time. The appearance can vary, making a professional medical evaluation essential for accurate identification. Causes and Risk Factors The exact cause of sebaceous carcinoma, like other cancers, lies in genetic mutations that transform healthy cells into cancerous ones. In sebaceous carcinoma, these mutations affect the cells within the sebaceous glands. While the specific triggers for these mutations are not fully understood, research suggests potential roles for environmental factors, such as prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds. Several factors can increase the risk of developing sebaceous carcinoma: Age: It typically affects adults over the age of 40, with the highest incidence observed in individuals between 60 and 80 years old. However, rare cases have been reported in children. Gender and Ethnicity: Studies have shown variations in prevalence based on geographic location. In Western countries, it is more common in males and white individuals. Conversely, in Asian countries like China, India, and Korea, it constitutes a larger proportion of eyelid cancers and appears to be more prevalent in females. Muir-Torre Syndrome: This is a rare genetic disorder characterized by an increased risk of developing tumors in the sebaceous glands and other internal organs. Weakened Immune System: Individuals with compromised immune systems, such as those with HIV or who have undergone organ transplantation, may have a higher susceptibility to certain cancers, including sebaceous carcinoma. Diagnosis of Sebaceous Carcinoma Diagnosing sebaceous carcinoma often requires the expertise of specialists. While a primary care physician might suspect the condition based on its appearance, a referral to an ophthalmologist (for eyelid tumors) or a dermatologist (for tumors elsewhere) is usually necessary. The diagnostic process typically involves: Medical History and Physical Examination: The doctor will inquire about your symptoms, medical history, and any risk factors. A thorough examination of the affected area will be performed. Biopsy: The definitive diagnosis is made through a biopsy, where a small sample of the suspicious tissue is removed and examined under a microscope by a pathologist. This allows for the confirmation of cancerous cells and their type. For sebaceous carcinomas that do not involve the eyelids, doctors may use the AJCC's TNM staging system, commonly employed for nonmelanoma skin cancers. This system helps determine the extent of the cancer's spread, with stages ranging from 0 to 4. Treatment Options The treatment approach for sebaceous carcinoma depends on the size, location, and stage of the cancer. The primary goal is to remove the cancerous cells completely while preserving the function and appearance of the affected area, especially on the eyelids. Surgical Excision: This is the most common treatment. The surgeon removes the tumor along with a margin of healthy tissue to ensure all cancerous cells are eliminated. For eyelid tumors, specialized techniques like Mohs surgery may be used to maximize tissue preservation and achieve clear margins. Radiation Therapy: In some cases, radiation therapy may be used after surgery to destroy any remaining cancer cells or as a primary treatment if surgery is not feasible. Chemotherapy: Chemotherapy is generally not the primary treatment for sebaceous carcinoma but may be considered for advanced
In summary, timely diagnosis, evidence-based treatment, and prevention-focused care improve long-term health outcomes.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026